Abstract
The second most common primary liver cancer is intrahepatic cholangiocarcinoma (iCCA). The only potentially curative treatment for iCCA is surgical resection, although the majority of patients will present with unresectable, locally advanced, or metastatic disease at diagnosis. The focus of surgical management is margin-negative resection with preservation of an adequate liver remnant volume and function. Extensive liver resection including adjacent involved structures such as the extrahepatic bile duct, major vessels, and diaphragm may be required to achieve negative resection margins. For patients with high-risk features, the routine use of diagnostic laparoscopy with the selective use of laparoscopic ultrasonography is recommended to identify occult metastatic disease. Among the prognostic factors such as lymph node (LN) involvement, tumor size, multicentricity, margin status, tumor differentiation, and vascular invasion, LN metastasis is the most important prognostic factor for patients undergoing curative-intent resection. Regional lymphadenectomy is recommended at the time of hepatectomy due to the high incidence of LN metastasis and its prognostic relevance. Even in patients who undergo R0 resection, the recurrence rates are high and the long-term survival remains poor. Despite the poor outcomes of liver transplantation for iCCA, liver transplantation may be a therapeutic option for selected patients with early-stage iCCA, especially for patients with an adequate response to neoadjuvant therapy.
Similar content being viewed by others
References
Lubezky N, Facciuto M, Harimoto N, et al. Surgical treatment of intrahepatic cholangiocarcinoma in the USA. J Hepatobiliary Pancreat Sci. 2015;22(2):124–30.
Rahnemai-Azar AA, Weisbrod AB, Dillhoff M, et al. Intrahepatic cholangiocarcinoma: current management and emerging therapies. Expert Rev Gastroenterol Hepatol. 2017;11(5):439–49.
Shaib YH, Davila JA, McGlynn K, et al. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 2004;40(3):472–7.
Squires MH, Cloyd JM, Dillhoff M, et al. Challenges of surgical management of intrahepatic cholangiocarcinoma. Expert Rev Gastroenterol Hepatol. 2018;12(7):671–81.
Weber SM, Ribero D, O’Reilly EM, et al. Intrahepatic cholangiocarcinoma: expert consensus statement. HPB. 2015;17(8):669–80.
Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60(6):1268–89.
Endo I, Gonen M, Yopp AC, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008;248(1):84–96.
Machairas N, Lang H, Jayant K, et al. Intrahepatic cholangiocarcinoma: limitations for resectability, current surgical concepts and future perspectives. Eur J Surg Oncol. 2020;46(5):740–6 https://doi.org/10.1016/j.ejso.2020.01.028.
Wang K, Zhang H, Xia Y, et al. Surgical options for intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr. 2017;6(2):79–90.
Buettner S, van Vugt JL, IJermans JN, et al. Intrahepatic cholangiocarcinoma: current perspectives. Onco Targets Ther. 2017;20:1131–42.
Waisberg DR, Pinheiro RS, Nacif LS, et al. Resection for intrahepatic cholangiocellular cancer: new advances. Transl Gastroenterol Hepatol. 2018;3:60.
Nagino M, Kamiya J, Nishio H, et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer. Surgical outcome and long-term follow-up. Ann Surg. 2006;243:364–72.
Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990;107:521–7.
Chaudhary RJ, Higuchi R, Nagino M, et al. Survey of preoperative management protocol for perihilar cholangiocarcinoma at 10 Japanese high-volume centers with a combined experience of 2,788 cases. J Hepatobiliary Pancreat Sci. 2019;26:490–502.
Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg. 2001;88:165–75.
Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;255:405–14.
Bednarsch J, Czigany Z, Lurje I, et al. The role of ALPPS in intrahepatic cholangiocarcinoma. Langenbeck’s Arch Surg. 2019;404(7):885–94.
Schadde E, Raptis DA, Schnitzbauer AA, et al. Prediction of mortality after ALPPS stage-1: an analysis of 320 patients from the international ALPPS registry. Ann Surg. 2015;262:780–5. Discussion 785–6
D’Angelica M, Fong Y, Weber S, et al. The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases. Ann Surg Oncol. 2003;10:183–9.
Goere D, Wagholikar GD, Pessaux P, et al. Utility of staging laparoscopy in subsets of biliary cancers: laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc. 2006;20:721–5.
de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011;29:3140–5.
Altman AM, Kizy S, Marmor S, et al. Current survival and treatment trends for surgically resected intrahepatic cholangiocarcinoma in the United States. J Gastrointest Oncol. 2018;9(5):942–52.
Amin MB, Edge S, Greene F, et al. American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging manual. 8th ed. Chicago: Springer; 2017.
Bagante F, Spolverato G, Merath K, et al. Intrahepatic cholangiocarcinoma tumor burden: a classification and regression tree model to define prognostic groups after resection. Surgery. 2019;166(6):983–90.
Farges O, Fuks D, Boleslawski E, et al. Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group. Ann Surg. 2011;254(5):824–9. Discussion 830
Spolverato G, Yakoob MY, Kim Y, et al. The impact of surgical margin status on long-term outcome after resection for intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2015;22(12):4020–8.
Zhang XF, Beal EW, Bagante F, et al. Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent. Br J Surg. 2018;105:848–56.
Buell JF, Cherqui D, Geller DA, et al. The international position on laparoscopic liver surgery: the Louisville statement, 2008. Ann Surg. 2009;250:825–30.
Wakabayashi G, Cherqui D, Geller DA, et al. Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg. 2015;261:619–29.
Kinoshita M, Kanazawa A, Takemura S, et al. Indications for laparoscopic liver resection of mass forming intrahepatic cholangiocarcinoma. Asian J Endosc Surg. 2019:1–3. https://doi.org/10.1111/ases.12703.
Lee W, Park JH, Kim JY, et al. Comparison of perioperative and oncologic outcomes between open and laparoscopic liver resection for intrahepatic cholangiocarcinoma. Surg Endosc. 2016;30:4835–40.
Ratti F, Cipriani F, Ariotti R, et al. Safety and feasibility of laparoscopic liver resection with associated lymphadenectomy for intrahepatic cholangiocarcinoma: a propensity score-based case-matched analysis from a single institution. Surg Endosc. 2016;30:1999–2010.
Uy BJ, Han HS, Yoon YS, et al. Laparoscopic liver resection for intrahepatic cholangiocarcinoma. J Laparoendosc Adv Surg Tech A. 2015;25:272–7.
Wei F, Lu C, Cai L, et al. Can laparoscopic liver resection provide a favorable option for patients with large or multiple intrahepatic cholangiocarcinomas? Surg Endosc. 2017;31:3646–55.
Abu Hilal M, Badran A, Di Fabio F, et al. Pure laparoscopic en bloc left hemihepatectomy and caudate lobe resection in patients with intrahepatic cholangiocarcinoma. J Laparoendosc Adv Surg Tech A. 2011;21:845–9.
Ratti F, Cipriani F, Ariotti R, et al. Laparoscopic major hepatectomies: current trends and indications. A comparison with the open technique. Updat Surg. 2015;67:157–67.
Zhu Y, Song J, Xu X, et al. Safety and feasibility of laparoscopic liver resection for patients with large or multiple intrahepatic cholangiocarcinomas: a propensity score based case-matched analysis from a single institute. Medicine. 2019;98(49):e18307.
Zamora-Valdes D, Heimbach JK. Liver transplant for cholangiocarcinoma. Gastroenterol Clin N Am. 2018;47:267–80.
Sapisochin G, Facciuto M, Rubbia-Brandt L, et al. Liver transplantation for “very early” intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment. Hepatology. 2016;64(4):1178–88.
Lunsford KE, Javle M, Heyne K, et al. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case series. Lancet Gastroenterol Hepatol. 2018;3:337–48.
Moris D, Kostakis ID, Machairas N, et al. Comparison between liver transplantation and resection for hilar cholangiocarcinoma: a systematic review and meta-analysis. PLoS One. 2019;14:e0220527.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this entry
Cite this entry
Kim, KH., Park, JI. (2021). Surgical Treatment of Intrahepatic Cholangiocarcinoma. In: Doria, C., Rogart, J.N. (eds) Hepato-Pancreato-Biliary Malignancies. Springer, Cham. https://doi.org/10.1007/978-3-030-37482-2_17-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-37482-2_17-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-37482-2
Online ISBN: 978-3-030-37482-2
eBook Packages: Springer Reference MedicineReference Module Medicine